RaySearch Laboratories AB

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-05-16 am EDT			5-day change	1st Jan Change
127.2 ^SEK	+3.08%		-0.16%	+40.86%

May. 06	C-RAD Partners with RaySearch Laboratories to Improve Radiation Therapy	MT
May. 04	RaySearch Laboratories AB and C-RAD Sign Collaboration Agreement	CI

Raysearch Laboratories AB Appoints Henrik Bergentoft as Cfo, Effective from November 15, 2022

August 29, 2022 at 01:45 am EDT

RaySearch Laboratories AB (publ) announced that Henrik Bergentoft was appointed new CFO at RaySearch and will take up his position November 15, 2022.

Latest news about RaySearch Laboratories AB

C-RAD Partners with RaySearch Laboratories to Improve Radiation Therapy	May. 06	MT
RaySearch Laboratories AB and C-RAD Sign Collaboration Agreement	May. 04	CI
Raysearch to Present the Latest Advances in Raystation, Raycare and Rayintelligence At Estro 2024	May. 02	CI
National Institutes for Quantum Science and Technology Selects RaySearch Laboratories AB for Clinical Use at the QST Hospital	Apr. 11	CI
Transcript : RaySearch Laboratories AB, 2023 Earnings Call, Feb 23, 2024	Feb. 23
RaySearch Laboratories AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 23	CI
RaySearch Laboratories AB Proposes an Extra Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024	Feb. 23	CI
RaySearch Laboratories AB Proposes Ordinary Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024	Feb. 23	CI
Pharmacolog Sells Druglog Product Line to RaySearch Laboratories	Feb. 09	MT
RaySearch Laboratories AB (OM:RAY B) acquired product line Druglog of Pharmacolog AB for SEK 8.5 million.	Feb. 08	CI
The Royal Marsden Nhs Foundation Trust to Implement Online Adaptiation Therapy Utilizing Artemis from Raysearch	Feb. 08	CI
The Froedtert & Medical College of Wisconsin Health Network Selects RayStation	Jan. 18	CI
RaySearch Laboratories AB Releases Raystation 2024A	Dec. 22	CI
Vejle Hospital Becomes First Center in the World to Use RayStation for an Online Adaptive Treatment with Augmented CBCT	Nov. 20	CI
Transcript : RaySearch Laboratories AB, Q3 2023 Earnings Call, Nov 17, 2023	Nov. 17
RaySearch Laboratories AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Oregon Health & Science University to Utilize RayStation Technology for Radiation Therapy Planning	23-10-31	CI
Baptist Health Lexington Selects RayStation	23-10-26	CI
Prominent U.S. Hospital Expands Raystation Installation for Proton Treatment Planning	23-10-13	CI
RaySearch Laboratories and Mevion Medical Systems to Develop New Proton Therapy Solutions in Support of Current and Emerging Technologies	23-10-02	CI
Paul Scherrer Institute Selects RayStation	23-10-02	CI
RaySearch Laboratories AB Deepens Collaboration with P-Cure	23-10-01	CI
RaySearch Receives Order for RayStation and RayCare in Italy	23-09-29	CI
RaySearch Laboratories AB and EBG MedAustron GmbH Expands Their Partnership	23-09-29	CI
RaySearch to Showcase Latest Innovations in Raystation, RayCare and RayIntelligence to Be Presented at ASTRO 2023	23-09-29	CI

Chart RaySearch Laboratories AB

Duration

Period

More charts

RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Companyâs products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Companyâs commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Sector

Advanced Medical Equipment & Technology

Calendar

01:45am - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for RaySearch Laboratories AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

127.2 SEK

Average target price

135 SEK

Spread / Average Target

+6.13%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
RAYSEARCH LABORATORIES AB	+40.86%	396M
VEEVA SYSTEMS INC.	+8.90%	34.16B
PRO MEDICUS LIMITED	+24.97%	8.13B
SECTRA AB	+30.59%	4.44B
EVOLENT HEALTH, INC.	-29.43%	2.7B
OMNICELL, INC.	-15.87%	1.37B
VERADIGM INC.	-25.17%	1.27B
LUNIT INC.	-33.46%	1.18B
SIMULATIONS PLUS, INC.	+12.19%	1B
B-SOFT CO.,LTD.	-36.34%	870M

Medical Software & Technology Services